TREATMENT OF HIGH-GRADE NON-HODGKIN LYMPHOMA - RESULTS OF A PHASE-II AND A PHASE-III TRIAL

被引:0
作者
KOPPLER, H [1 ]
PFLUGER, KH [1 ]
HAVEMANN, K [1 ]
ESCHENBACH, I [1 ]
PFAB, R [1 ]
LENNERT, K [1 ]
WELLENS, W [1 ]
SCHMIDT, M [1 ]
GASSEL, WD [1 ]
KOLB, R [1 ]
HASSLER, R [1 ]
SCHUMACHER, K [1 ]
VONSPETH, G [1 ]
GROPP, C [1 ]
HIRSCHMANN, WD [1 ]
GOSSMANN, HH [1 ]
OHL, S [1 ]
DRINGS, P [1 ]
HOSSFELD, DK [1 ]
BRUNTSCH, U [1 ]
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
来源
BLUT | 1988年 / 57卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:220 / 220
页数:1
相关论文
共 50 条
[21]   High-grade non-Hodgkin's lymphoma of ovary presenting as peritonitis [J].
Pandey, Salil ;
Devanand, B. ;
John, B. Joseph ;
Singh, Gursharan ;
Sivanandam, Santhakumari ;
Leelakrishnan, Venkatakrishnan .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) :663
[22]   Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas [J].
Çelik, I ;
Kars, A ;
Güler, N ;
Barista, I ;
Tekuzman, G ;
Özyilkan, Ö ;
Hayran, M ;
Firat, D .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) :759-760
[23]   A PHASE-II STUDY OF ORAL PIRITREXIM IN RECURRENT HIGH-GRADE (III, IV) GLIOMA [J].
BLEEHEN, NM ;
NEWMAN, HVF ;
RAMPLING, RP ;
RAMSAY, JR ;
ROBERTS, JT ;
BEDFORD, P ;
NETHERSELL, ABW .
BRITISH JOURNAL OF CANCER, 1995, 72 (03) :766-768
[24]   Phase II study of fludarabine and cyclophosphamide in the treatment of relapsed low grade non-Hodgkin's lymphoma. [J].
Lucie, NP ;
Dunlop, DJ ;
Soukop, M ;
McKay, PJ ;
Stark, AN ;
Anderson, SM ;
Paul, J .
BLOOD, 2001, 98 (11) :606A-607A
[25]   A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL [J].
SCHAID, DJ ;
INGLE, JN ;
WIEAND, S ;
AHMANN, DL .
CONTROLLED CLINICAL TRIALS, 1988, 9 (02) :107-118
[26]   PHASE-II TRIAL OF TEMOZOLOMIDE IN LOW-GRADE NON-HODGKINS-LYMPHOMA [J].
WOLL, PJ ;
CROWTHER, D ;
JOHNSON, PWM ;
SOUKOP, M ;
HARPER, PG ;
HARRIS, M ;
BRAMPTON, MH ;
NEWLANDS, ES .
BRITISH JOURNAL OF CANCER, 1995, 72 (01) :183-184
[27]   A new protocol (MiCEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly [J].
Bellesi, G ;
Rigacci, L ;
Alterini, R ;
Bernardi, F ;
Stefanacci, S ;
Innocenti, F ;
Fusco, I ;
Longo, G ;
diLollo, S ;
Ferrini, PR .
LEUKEMIA & LYMPHOMA, 1996, 20 (5-6) :475-480
[28]   Phase II trial of Doxil® in patients with refractory/relapsed low-grade non-Hodgkin's lymphoma. [J].
Di Bella, NJ ;
Khan, MM ;
Dakhil, SR ;
Logie, KW ;
Marsland, TA ;
Simon, SR ;
Weinstein, RE .
BLOOD, 2000, 96 (11) :236B-236B
[29]   SEQUENTIAL COMBINATION CHEMOTHERAPY (CABOPP/VIM) FOR THE TREATMENT OF HIGH-GRADE MALIGNANT NON-HODGKIN LYMPHOMA [J].
NOWROUSIAN, MR ;
MEIER, CR ;
SCHOETENSACK, B ;
ANDERS, C ;
HOFFKEN, K ;
OSIEKA, R ;
SCHMIDT, CG .
ACTA ONCOLOGICA, 1989, 28 (04) :495-500